TICKER INTELLIGENCE

$LOPE

Company & Legislative Profile

$LOPE is a publicly traded company in the Healthcare sector. This company operates across Healthcare and is subject to various Congressional legislative and regulatory actions. HillSignal is tracking 3 active Congressional signals mentioning $LOPE, including 3 bills. The current legislative sentiment leans bearish, with regulatory or policy headwinds potentially affecting performance.

$LOPE is currently facing 3 active congressional signals tracked by HillSignal. With 0 bullish, 2 neutral, and 1 bearish signals, covering 2 sectors. Key sectors affected include Healthcare and Consumer. Recent major catalysts include A bill to amend the Higher Education Act of 1965 to provide for institutional ineligibility based on low cohort repayment rates and to require risk-sharing payments of institutions of higher education. and A bill to revise and extend health workforce programs under title VII of the Public Health Service Act.. Below is the complete tracker of government activity affecting $LOPE’s market performance.

3

Total Signals

2.0/10

Avg Impact

0

Bullish Signals

1

Bearish Signals

Related Sectors

Recent Congressional Signals for $LOPE

The Student Protection and Success Act (S. 4114) introduces a hard 15% cohort repayment rate cutoff that would strip federal student aid eligibility from non-compliant for-profit institutions, directly threatening the revenue model of companies like Perdoceo ($PRDO) and Grand Canyon Education ($LOPE). The bill is early-stage but its mechanism is precise and structural, leaving affected operators with no self-correcting defense. Over the past 30 days, $PRDO has declined 8.25% and $LOPE has declined 1.01%, with recent price action reflecting market digestion of this regulatory risk.

S4114Congressional Bill

HR2271, the Change of Ownership and Conversion Improvement Act, is an early-stage procedural bill that creates a fee-based expedited review process at the Department of Education for higher education ownership changes. It authorizes no spending and has no near-term market impact on any publicly traded company.

HR2271Congressional Bill

Understanding These Signals

Get Full Access to $LOPE Signals

Daily AI-analyzed alerts for Congressional activity affecting your portfolio.

Get Started →